Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 15, 2023
[ Wed, Mar 15th 2023
] - WOPRAI
Tue, March 14, 2023
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
[ Tue, Mar 14th 2023
] - WOPRAI
Gregory Renza Reiterated (VIRX) at Buy and Held Target at $8 on, Mar 14th, 2023
Gregory Renza of RBC Capital, Reiterated "Viracta Therapeutics, Inc." (VIRX) at Buy and Held Target at $8 on, Mar 14th, 2023.
Gregory, nor any peers, have made any analyst calls on VIRX in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30